Hantz Financial Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Hantz Financial Services, Inc.

$5.63 Billion
Q3 2024

A detailed history of Hantz Financial Services, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 73 shares of REGN stock, worth $55,247. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 39 87.18%

Holding current value

$55,247

Previous $41,000 87.8%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $34,819 - $40,859	34 Added 87.18%	73 $77,000
Q2 2024 Jul 30, 2024	BUY	$883.2 - $1071.19 $34,444 - $41,776	39 New	39 $41,000
Q3 2023 Aug 06, 2024	SELL	$692.45 - $844.37 $15,926 - $19,420	-23 Reduced 40.35%	34 $28,000
Q2 2023 Aug 06, 2024	SELL	$700.03 - $830.35 $23,100 - $27,401	-33 Reduced 36.67%	57 $41,000
Q4 2022 Aug 06, 2024	SELL	$705.89 - $766.39 $21,882 - $23,758	-31 Reduced 25.62%	90 $65,000
Q3 2022 Aug 06, 2024	SELL	$573.97 - $724.32 $6,887 - $8,691	-12 Reduced 9.02%	121 $83,000
Q2 2022 Aug 06, 2024	SELL	$548.35 - $738.84 $16,450 - $22,165	-30 Reduced 18.4%	133 $79,000
Q1 2022 Aug 06, 2024	SELL	$595.12 - $698.43 $111,882 - $131,304	-188 Reduced 53.56%	163 $114,000
Q4 2021 Aug 06, 2024	BUY	$543.48 - $670.97 $75,543 - $93,264	139 Added 65.57%	351 $222,000
Q3 2021 Aug 06, 2024	SELL	$574.03 - $680.96 $1,722 - $2,042	-3 Reduced 1.4%	212 $128,000
Q2 2021 Aug 06, 2024	SELL	$472.8 - $558.54 $39,715 - $46,917	-84 Reduced 28.09%	215 $120,000
Q1 2021 Aug 06, 2024	BUY	$446.73 - $548.2 $116,149 - $142,532	260 Added 666.67%	299 $141,000
Q4 2020 Aug 06, 2024	BUY	$478.3 - $607.98 $371,639 - $472,400	777 Added 3.17%	25,260 $12.2 Million
Q3 2020 Aug 06, 2024	BUY	$544.75 - $658.21 $618,836 - $747,726	1,136 Added 4.87%	24,483 $13.7 Million
Q2 2020 Aug 06, 2024	BUY	$493.32 - $643.92 $554,985 - $724,410	1,125 Added 5.06%	23,347 $14.6 Million
Q1 2020 Aug 06, 2024	BUY	$336.18 - $494.43 $7.46 Million - $11 Million	22,183 Added 56879.49%	22,222 $10.9 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History